Skip to main content
Home Home

Main navigation

  • Home
  • Shop
    • Ordering information
    • Register
    • Distributors
    • Price list
  • Support
    • Contact us
    • ELISA FAQs
    • ELISA guidelines
    • ELISPOT & FluoroSpot FAQs
    • ELISPOT & FluoroSpot stimuli
    • T cell ELISPOT guidelines
    • B cell ELISPOT guidelines
    • FluoroSpot assay guidelines
    • Abbreviations
    • Manuals & SDS
  • Literature
    • ELISPOT in research
    • ELISA in research
    • Cytokines
    • Manuals & SDS
    • Reference Database
  • Our company
    • About Us
    • Feedback
    • Contract Services
    • Immunoassays
    • Company address

Products

  • ELISA
  • T cell ELISPOT
  • B cell ELISPOT
  • FluoroSpot
  • Antibodies
  • Auxiliary products
  • All products

Sign in for online shopping

  • Create new account
  • Reset your password

Special Offers

10% discount on blue ELISPOT kits (2 and 5 plates)
CT138
  1. Home
  2. Products
  3. B cell ELISPOT
  4. Mouse
  5. IgG
  6. Mouse IgG B cell ELISPOT kit

Mouse IgG B cell ELISPOT kit

Catalogue Number
CT790-B5
Description
Mouse IgG B cell ELISPOT kit - 5-plate
Price
€ 645.00
staining
Enzymatic
Characteristics
PVDF
Contents
  • Coating antibody (to determine total number IgG secreting B cells)
  • biotinylated detection antibody
  • B cell stimulus
  • Streptavidin-HRP conjugate
  • TMB substrate
  • Blocking stock solution
  • Dilution buffer
  • Tween-20
  • manual

References list

  • Adjuvant activity of cordycepin, a natural derivative of adenosine from on an inactivated rabies vaccine in an animal model.
    Chen, Xin, et al. Heliyon 2024 Jan 30;10(2): e24612
  • Self-adjuvant multiepitope nanovaccine based on ferritin induced long-lasting and effective mucosal immunity against H3N2 and H1N1 viruses in mice.
    Nie, Jiaojiao, et al. Int J Biol Macromol 2024 Feb;259(Pt 1): 129259
  • Inotodiol, an antiasthmatic agent with efficacy and safety, preferentially impairs membrane-proximal signaling for mast cell activation.
    Liu, Ye, et al. Int Immunopharmacol 2023 Feb 20;117: 109854
  • IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII.
    Matino, Davide, et al. J. Clin. Invest. 2015 Oct 01;125: 3766-81

Disclaimer menu

  • DESIGN VANDEEZ
  • © U-CyTech 1999-2025
  • TERMS & CONDITIONS
  • PRIVACY & COOKIE STATEMENT
Close menu